Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells

Free Radical Biology and Medicine

Volumn 77, Issue , 2014, Pages 307-316

  Zemke, Anna C ^a   Shiva, Sruti ^a   Burns, Jane L ^b   Moskowitz, Samuel M ^c   Pilewski, Joseph M ^a   Gladwin, Mark T ^a,d   Bomberger, Jennifer M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Biofilm; Colistimethate; Colistin; Polymyxin; Pseudomonas aeruginosa; Sodium nitrite

Indexed keywords

COLISTIMETHATE; NITRIC OXIDE; NITRITE; POLYMYXIN DERIVATIVE; SODIUM NITRITE; ANTIINFECTIVE AGENT; COLISTIN; OXYGEN;

AEROBIC CELL CULTURE; AIRWAY EPITHELIUM CELL; ANAEROBIC CELL CULTURE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BIOFILM; COCULTURE; CONTROLLED STUDY; DRUG POTENTIATION; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; ANTIBIOTIC RESISTANCE; BRONCHUS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; BIOFILMS; BRONCHI; CELLS, CULTURED; COLISTIN; DRUG RESISTANCE, BACTERIAL; EPITHELIAL CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; NITRIC OXIDE; OXYGEN; PSEUDOMONAS AERUGINOSA; SODIUM NITRITE;

EID: 84929625977     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.08.011     Document Type: Article

References (55)

1. Schaible, B.; Taylor, C. T.; Schaffer, K. Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps. Antimicrob. Agents Chemother. 56:2114-2118; 2012.
2. Mah, TF; Pitts, B; Pellock, B; Walker, GC; Stewart, PS; O'Toole, GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310; 2003.
3. Callaghan, M; McClean, S. Bacterial host interactions in cystic fibrosis. Curr. Opin. Microbiol. 15:71-77; 2012.
4. Yoon, SS; Hennigan, RF; Hilliard, GM; Ochsner, UA; Parvatiyar, K; Kamani, MC; Allen, HL; DeKievit, TR; Gardner, PR; Schwab, U; Rowe, JJ; Iglewski, BH; McDermott, TR; Mason, RP; Wozniak, DJ; Hancock, RE; Parsek, MR; Noah, TL; Boucher, RC; Hassett, DJ. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603; 2002.
5. Kolpen, M; Kuhl, M; Bjarnsholt, T; Moser, C; Hansen, CR; Liengaard, L; Kharazmi, A; Pressler, T; Hoiby, N; Jensen, PO. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLoS One 9:e84353; 2014.
6. Hill, D; Rose, B; Pajkos, A; Robinson, M; Bye, P; Bell, S; Elkins, M; Thompson, B; Macleod, C; Aaron, SD; Harbour, C. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J. Clin. Microbiol. 43:5085-5090; 2005.
7. Dykhuizen, RS; Fraser, A; McKenzie, H; Golden, M; Leifert, C; Benjamin, N. Helicobacter pylori is killed by nitrite under acidic conditions. Gut 42:334-337; 1998.
8. Cunningham, R; Mustoe, E; Spiller, L; Lewis, S; Benjamin, N. Acidified nitrite: a host defence against colonization with C. difficile spores? J. Hosp. Infect. 86:155-157; 2014.
9. Husain, M; Bourret, TJ; McCollister, BD; Jones-Carson, J; Laughlin, J; Vazquez-Torres, A. Nitric oxide evokes an adaptive response to oxidative stress by arresting respiration. J. Biol. Chem. 283:7682-7689; 2008.
10. Reddy, D; Lancaster Jr. JR; Cornforth, DP. Nitrite inhibition of Clostridium botulinum: electron spin resonance detection of iron-nitric oxide complexes. Science 221:769-770; 1983.
11. Rowe, JJ; Yarborough, JM; Rake, JB; Eagon, RG. Nitrite inhibition of aerobic bacteria. Curr. Microbiol. 2:51-54; 1979.
12. Kim-Shapiro, DB; Gladwin, MT. Mechanisms of nitrite bioactivation. Nitric Oxide; 2013.
13. Bueno, M; Wang, J; Mora, AL; Gladwin, MT. Nitrite signaling in pulmonary hypertension: mechanisms of bioactivation, signaling, and therapeutics. Antioxid. Redox Signal. 18:1797-1809; 2013.
14. Miller, C; McMullin, B; Ghaffari, A; Stenzler, A; Pick, N; Roscoe, D; Ghahary, A; Road, J; Av-Gay, Y. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric Oxide 20:16-23; 2009.
15. Miller, C; Miller, M; McMullin, B; Regev, G; Serghides, L; Kain, K; Road, J; Av-Gay, Y. A phase I clinical study of inhaled nitric oxide in healthy adults. J. Cyst. Fibros. 11:324-331; 2012.
16. Hon, YY; Sun, H; Dejam, A; Gladwin, MT. Characterization of erythrocytic uptake and release and disposition pathways of nitrite, nitrate, methemoglobin, and iron-nitrosyl hemoglobin in the human circulation. Drug Metab. Dispos. 38:1707-1713; 2010.
17. Yoon, SS; Coakley, R; Lau, GW; Lymar, SV; Gaston, B; Karabulut, AC; Hennigan, RF; Hwang, SH; Buettner, G; Schurr, MJ; Mortensen, JE; Burns, JL; Speert, D; Boucher, RC; Hassett, DJ. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 116:436-446; 2006.
18. Yang, T. Mechanism of nitrite inhibition of cellular respiration in Pseudomonas aeruginosa. Curr. Microbiol. 12:35-40; 1985.
19. Reszka, KJ; Xiong, Y; Sallans, L; Pasula, R; Olakanmi, O; Hassett, DJ; Britigan, BE. Inactivation of the potent Pseudomonas aeruginosa cytotoxin pyocyanin by airway peroxidases and nitrite. Am. J. Physiol. Lung Cell Mol. Physiol 302: L1044-L1056; 2012.
20. Wood, SR; Firoved, AM; Ornatowski, W; Mai, T; Deretic, V; Timmins, GS. Nitrosative stress inhibits production of the virulence factor alginate in mucoid Pseudomonas aeruginosa. Free Radic. Res. 41:208-215; 2007.
21. Major TA, Panmanee W, Mortensen JE, Gray LD, Hoglen N, Hassett DJ. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob. Agents Chemother.;54:4671-677.
22. Schlag, S; Nerz, C; Birkenstock, TA; Altenberend, F; Gotz, F. Inhibition of staphylococcal biofilm formation by nitrite. J. Bacteriol. 189:7911-7919; 2007.
23. Braun, C; Zumft, WG. Marker exchange of the structural genes for nitric oxide reductase blocks the denitrification pathway of Pseudomonas stutzeri at nitric oxide. J. Biol. Chem. 266:22785-22788; 1991.
24. Pamp, SJ; Gjermansen, M; Johansen, HK; Tolker-Nielsen, T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexab-oprm genes. Mol. Microbiol. 68:223-240; 2008.
25. Chiang, WC; Pamp, SJ; Nilsson, M; Givskov, M; Tolker-Nielsen, T. The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms. FEMS Immunol. Med. Microbiol. 65:245-256; 2012.
26. LaPorte, DC; Rosenthal, KS; Storm, DR. Inhibition of Escherichia coli growth and respiration by polymyxin b covalently attached to agarose beads. Biochemistry 16:1642-1648; 1977.
27. Haworth, CS; Foweraker, JE; Wilkinson, P; Kenyon, RF; Bilton, D. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 189:975-982; 2014.
28. CFF. Patient registry: annual data report. 2012.
29. Moskowitz, SM; Silva, SJ; Mayer-Hamblett, N; Pasta, DJ; Mink, DR; Mabie, JA; Konstan, MW; Wagener, JS. Shifting patterns of inhaled antibiotic use in cystic fibrosis. Pediatr. Pulmonol. 43:874-881; 2008.
30. Schuster, A; Haliburn, C; Doring, G; Goldman, MH. Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (colobreathe dpi) in patients with cystic fibrosis: a randomised study. Thorax 68:344-350; 2013.
31. Moreau-Marquis, S; Bomberger, JM; Anderson, GG; Swiatecka-Urban, A; Ye, S; O'Toole, GA; Stanton, BA. The deltaf508-cftr mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am. J. Physiol. Lung Cell Mol. Physiol 295:L25-L37; 2008.
32. Smith, EE; Buckley, DG; Wu, Z; Saenphimmachak, C; Hoffman, LR; D'Argenio, DA; Miller, SI; Ramsey, BW; Speert, DP; Moskowitz, SM; Burns, JL; Kaul, R; Olson, MV. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 103:8487-8492; 2006.
33. Spilker, T; Vandamme, P; Lipuma, JJ. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J. Clin. Microbiol. 50:3010-3015; 2012.
34. Miller, AK; Brannon, MK; Stevens, L; Johansen, HK; Selgrade, SE; Miller, SI; Hoiby, N; Moskowitz, SM. Phoq mutations promote lipid a modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob. Agents Chemother. 55:5761-5769; 2011.
35. Heydorn, A; Nielsen, AT; Hentzer, M; Sternberg, C; Givskov, M; Ersboll, BK; Molin, S. Quantification of biofilm structures by the novel computer program comstat. Microbiology 146(Pt 10):2395-2407; 2000.
36. Moreau-Marquis S, Redelman CV, Stanton BA, Anderson GG. Co-culture models of Pseudomonas aeruginosa biofilms grown on live human airway cells. J. Vis. Exp. 2010. and Medicine 77 (2014) 307-316
37. Rasgado-Flores, H; Krishna Mandava, V; Siman, H; Van Driessche, W; Pilewski, JM; Randell, SH; Bridges, RJ. Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors. Am. J. Physiol. Cell Physiol 305:C1114-C1122; 2013.
38. Wiegand, I; Hilpert, K; Hancock, RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3:163-175; 2008.
39. Ratjen, F; Rietschel, E; Kasel, D; Schwiertz, R; Starke, K; Beier, H; van Koningsbruggen, S; Grasemann, H. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J. Antimicrob. Chemother. 57:306-311; 2006.
40. S, WSY; Li, J; Patel, K; Wilson, JW; Dooley, MJ; George, J; Clark, D; Poole, S; Williams, E; Porter, CJ; Nation, RL; McIntosh, MP. Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration. Antimicrob. Agents Chemother. 58:2570-2579; 2014.
41. Williams, DR; Rowe, JJ; Romero, P; Eagon, RG. Denitrifying Pseudomonas aeruginosa: some parameters of growth and active transport. Appl. Environ. Microbiol. 36:257-263; 1978.
42. Hernandez, DD; Rowe, F. M. J.J. Nitrate transport and its regualtion by O2 in Pseudomonas aeruginosa. Arch. Biochem. Biophys. 286:159-163; 1991.
43. Daugelavicius, R; Bakiene, E; Bamford, DH. Stages of polymyxin b interaction with the Escherichia coli cell envelope. Antimicrob. Agents Chemother. 44:2969-2978; 2000.
44. Champlin, FR; Ellison, ML; Bullard, JW; Conrad, RS. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 26:159-164; 2005.
45. Gusarov, I; Shatalin, K; Starodubtseva, M; Nudler, E. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325:1380-1384; 2009.
46. McCaughey, G; Gilpin, DF; Schneiders, T; Hoffman, LR; McKevitt, M; Elborn, JS; Tunney, MM. Fosfomycin and tobramycin in combination downregulate nitrate reductase genes NarG and NarH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions. Antimicrob. Agents Chemother. 57:5406-5414; 2013.
47. Yoon, SS; Karabulut, AC; Lipscomb, JD; Hennigan, RF; Lymar, SV; Groce, SL; Herr, AB; Howell, ML; Kiley, PJ; Schurr, MJ; Gaston, B; Choi, KH; Schweizer, HP; Hassett, DJ. Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration. EMBO J. 26:3662-3672; 2007.
48. Su, S; Panmanee, W; Wilson, JJ; Mahtani, HK; Li, Q; Vanderwielen, BD; Makris, TM; Rogers, M; McDaniel, C; Lipscomb, JD; Irvin, RT; Schurr, MJ; Lancaster Jr. JR; Kovall, RA; Hassett, DJ. Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS One 9:e91813; 2014.
49. Qu, W; Zhou, Y; Sun, Y; Fang, M; Yu, H; Li, W; Liu, Z; Zeng, J; Chen, C; Gao, C; Jia, J. Identification of s-nitrosylation of proteins of Helicobacter pylori in response to nitric oxide stress. J. Microbiol. 49:251-256; 2011.
50. Rhee, KY; Erdjument-Bromage, H; Tempst, P; Nathan, CF. S-Nitroso proteome of Mycobacterium tuberculosis: enzymes of intermediary metabolism and antioxidant defense. Proc. Natl. Acad. Sci. USA 102:467-472; 2005.
51. Bourret, TJ; Boylan, JA; Lawrence, KA; Gherardini, FC. Nitrosative damage to free and zinc-bound cysteine thiols underlies nitric oxide toxicity in wild-type borrelia burgdorferi. Mol. Microbiol. 81:259-273; 2011.
52. Chouchani, ET; Methner, C; Nadtochiy, SM; Logan, A; Pell, VR; Ding, S; James, AM; Cocheme, HM; Reinhold, J; Lilley, KS; Partridge, L; Fearnley, IM; Robinson, AJ; Hartley, RC; Smith, RA; Krieg, T; Brookes, PS; Murphy, MP. Cardioprotection by s-nitrosation of a cysteine switch on mitochondrial complex I. Nat. Med 19:753-759; 2013.
53. Shiva, S; Sack, MN; Greer, JJ; Duranski, M; Ringwood, LA; Burwell, L; Wang, X; MacArthur, PH; Shoja, A; Raghavachari, N; Calvert, JW; Brookes, PS; Lefer, DJ; Gladwin, MT. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med. 204:2089-2102; 2007.
54. Ren, B; Zhang, N; Yang, J; Ding, H. Nitric oxide-induced bacteriostasis and modification of iron-sulphur proteins in Escherichia coli. Mol. Microbiol. 70:953-964; 2008.
55. Bowman, LA; McLean, S; Poole, RK; Fukuto, JM. The diversity of microbial responses to nitric oxide and agents of nitrosative stress close cousins but not identical twins. Adv. Microb. Physiol. 59:135-219; 2011.